Is private hospital insurance really necessary?

Do you really need to go for the highest ward class Integrated Shield (IP) plan? Or would a basic integrated shield plan suffice? Read our article to find out what your options are and see if a private ward hospitalisation plan is what you really need.

iFAST Insurance Team
iFAST Insurance Team10 Oct 2024 10558 Views


A quick refresher on what makes up your hospitalisation coverage in Singapore

All Singaporeans and Permanent Residents (PRs) in Singapore are eligible for MediShield Life. This is a basic health insurance plan that is administered by the Central Provident Fund (CPF) Board and offers coverage for Class B2 or C wards in public hospitals.

Individuals may opt for Integrated Shield (IP) plans by private insurers if they wish to seek treatment at Class A or B1 wards in public hospitals, or private hospitals. IP riders can also be added on to cover for deductibles, and further enhance coverage.

(Source: https://www.moh.gov.sg/healthcare-schemes-subsidies/medishield-life)

Many people may by default opt for the highest-tier integrated shield (IP) plan for private hospital coverage. But is this necessary? Here are factors to consider when choosing a hospital plan.


1. Can you afford your IP premiums?

From 1 September 2024, integrated shield (IP) plan premiums have increased.

Major insurers like AIA, Income Insurance, Singlife, Great Eastern, and Prudential have stated that they will be raising the premiums for their integrated shield plans after 31 August 2024. This means that you are likely to experience higher premiums upon your next policy renewal.

For ease of comparison, we’ve compiled the difference in the total premiums (includes portion payable by Medisave) for the following insurers:

  • IncomeShield – Premiums for Enhanced IncomeShield Preferred, Advantage, and Basic have been adjusted with effect from 1 September 2024.
  • Raffles Shield – No changes to their IP premiums for now.
  • Singlife Shield – Premiums for Singlife Shield Plan 1 and Health Plus have been adjusted with effect from 1 September 2024. No changes to premiums for Singlife Shield Plan 2, 3, Starter, and Standard Plan.
  • Premiums shown are retrieved on 3 October 2024 for policies issued on standard terms, and are for illustration purposes only.

    With this recent increase in premiums and potential future premium hikes, ask yourself if your integrated shield plan is still affordable now, and can you continue affording it in future?


    2. Which ward class will you seek medical treatment at?

    Do you go straight to private hospitals when you need medical treatment? Or do you first visit a polyclinic to get a referral for treatment at public hospitals? While getting the highest tiered integrated shield plan will allow you to seek treatment at private hospitals, what if this is not what you need? If you tend to choose public hospitals for your medical treatments, then you may not actually need an IP plan with private hospital coverage.

    According to the Ministry of Health, about half of patients with IP and rider protection end up using subsidised public healthcare for hospitalisation or day surgery. If this group of individuals had been paying for private hospital IP plans, they may have then been paying for coverage that they do not need. If you are guilty of also doing so, then it is time to reconsider your IP coverage.

    Ward entitlement for the various IP plans:


    Income

    Raffles

    Singlife

    Private hospital
    Enhanced IncomeShield Preferred
    Raffles Shield Private
    Singlife Shield Plan 1
    Class A wards in public hospitals
    Enhanced IncomeShield Advantage
    Raffles Shield A
    Singlife Shield Plan 2
    Class B1 wards in public hospitals
    Enhanced IncomeShield Basic
    Raffles Shield B
    Singlife Shield Plan 3

    Alternatively, if you feel that your premiums are getting unaffordable, reassess your budget and determine if the additional cost is worth the benefits provided.


    If you want private care, shorter waiting times for appointments and procedures, or have a specific doctor that you visit for treatments:

    Get an IP plan with private hospital coverage. This ensures that you are adequately insured for your hospitalisation needs, and prevent you from having to pay high out-of-pocket expenses in the event of hospitalisation.

    For treatment at private hospitals, here are the integrated shield plans we have available on FSMOne:

    Private hospital integrated shield plans available on FSMOne


    Enhanced IncomeShield Preferred

    Raffles Shield Private

    Singlife Shield Plan 1

    Ward entitlement
    Private hospital
    Annual policy limit
    $1,500,000
    $1,500,000 for in-panel, and $600,000 for non-panel
    $2,000,000 for A&E or preferred medical providers, and $1,000,000 for others
    Annual premiums (from 1 September 2024)
    Age 30
    $267.00
    $225.13
    $268.00
    Age 40
    $373.00
    $348.40
    $428.00
    Age 50
    $1,009.00
    $643.81
    $1,213.00
    Age 60
    $1,687.00
    $1,076.76
    $1,892.00

    Premiums shown are retrieved on 3 October 2024 for policies issued on standard terms, and are for illustration purposes only.


    Reconsider your choice of getting the “highest” ward class coverage if…

    your approach is to go for subsidised care at public hospitals. Downgrading to the next tier of coverage (i.e. plans with Class A ward or Class B1 wards in public hospitals) may adequately address your needs at a more affordable cost for you.

    Class A ward integrated shield plans available on FSMOne


    Enhanced IncomeShield Advantage

    Raffles Shield A

    Singlife Shield Plan 2

    Ward entitlement
    Class A wards in public hospitals
    Annual policy limit
    $500,000
    $600,000
    $1,000,000
    Annual premiums (from 1 September 2024)
    Age 30
    $58.00
    $90.67
    $100.85
    Age 40
    $125.00
    $128.36
    $171.14
    Age 50
    $251.00
    $225.13
    $346.36
    Age 60
    $436.00
    $382.01
    $503.23

    Premiums shown are retrieved on 3 October 2024 for policies issued on standard terms, and are for illustration purposes only.

    Have a question? Click the button below if you would like a complimentary review from our team





    Available Products on FSMOne Insurance

    Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


    from AIG, Allianz, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.


    *Please check with our team if the product you want is available on FSMOne Insurance



    You may also be interested in...

    PSA: Is the insurance policy your parents bought for you serving you well?

    1 in 5 Singaporeans lack life insurance coverage. Are you the 1 in 5?

    Given the recent updates to the Integrated Shield Plan, is it advisable to rely on my company insurance for hospital coverage?

    Insurance is your subscription plan against life's uncertainties



    Information obtained from:

    https://www.moh.gov.sg/healthcare-schemes-subsidies/medishield-life

    https://www.businesstimes.com.sg/wealth/five-seven-insurers-jack-private-hospital-premiums-under-integrated-shield-plans-some-double-digits

    https://www.income.com.sg/kcassets/2a30f5fc-c64d-4c30-8818-ca0ffaf93e98/Premium%20Table%20for%20Enhanced%20IncomeShield%20and%20IncomeShield%20Standard%20Plan.pdf

    https://www.income.com.sg/kcassets/57771d4e-8109-4258-b37c-106664279ad6/Premium%20Table%20EIS.pdf

    https://singlife.com/content/dam/public/sg/documents/medical-insurance/singlife-health-plus/Singlife-Shield-HealthPlus-PremiumRates.pdf

    https://singlife.com/content/dam/public/sg/documents/medical-insurance/singlife-health-plus/premium-rates.pdf

    https://www.raffleshealthinsurance.com/wp-content/uploads/2021/03/Raffles-Shield-Product-Summary-1-April-2024-Finalv1-1.pdf

    https://www.moh.gov.sg/news-highlights/details/medishield-life-adequacy-and-ip-consumer-education#:~:text=To%20illustrate%2C%20about%20half%20of,the%20major%20review%20this%20year

    Information retrieved on 3 October 2024.



    Disclaimer:

    All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This article is not a contract of insurance.

    Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.

    You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.

    While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.

    Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.

    This advertisement has not been reviewed by the Monetary Authority of Singapore.

    All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

    Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

    iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.